LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for AsclepiX Therapeutics and Millions of Other Companies

Sign up for full access to AsclepiX Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Funding Strength AsclepiX Therapeutics has successfully raised multiple rounds of funding, with the recent Series A3 funding round bringing in $10 million. This strong financial backing signifies potential for investment in innovative retinal disease treatments.

Notable Leadership The company boasts a talented leadership team, including industry experts like Chief Scientific Officer Amir Shojaei and Chief Medical Officer Theresa G. H. Heah. Leveraging the expertise of these key personnel could open doors for strategic partnerships and collaborations.

Cutting-Edge Technology Utilizing computational biology and advanced technologies like AXT107, AsclepiX Therapeutics is at the forefront of developing novel peptide-based treatments for retinal diseases. This technology-driven approach presents an opportunity for partnerships with tech-savvy organizations seeking innovative healthcare solutions.

Market Recognition AsclepiX Therapeutics' funding milestones and high-profile appointments have garnered attention within the biotech industry. This recognition can be leveraged to build credibility among potential investors, paving the way for discussions on commercial collaborations and expansion opportunities.

Strategic Positioning Among its competitors, such as MyoKardia and Passage Bio, AsclepiX Therapeutics stands out for its focus on retinal disease treatments. This unique positioning could serve as a competitive advantage in identifying niche market segments and tailored sales strategies.

Similar companies to AsclepiX Therapeutics

✕

Access Insights for AsclepiX Therapeutics and Millions of Other Companies

Sign up for full access to AsclepiX Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

AsclepiX Therapeutics Tech Stack

AsclepiX Therapeutics uses 8 technology products and services including WordPress, Google Font API, Choices, and more. Explore AsclepiX Therapeutics's tech stack below.

  • WordPress
    Content Management System
  • Google Font API
    Font Scripts
  • Choices
    Javascript Libraries
  • Tippy.js
    Javascript Libraries
  • RSS
    Miscellaneous
  • Priority Hints
    Performance
  • reCAPTCHA
    Security
  • Nginx
    Web Servers

Media & News

AsclepiX Therapeutics's Email Address Formats

AsclepiX Therapeutics uses at least 1 format(s):
AsclepiX Therapeutics Email FormatsExamplePercentage
FLast@asclepix.comJDoe@asclepix.com
45%
LastFirst@asclepix.comDoeJohn@asclepix.com
5%
FLast@asclepix.comJDoe@asclepix.com
45%
LastFirst@asclepix.comDoeJohn@asclepix.com
5%

Frequently Asked Questions

Where is AsclepiX Therapeutics's headquarters located?

Minus sign iconPlus sign iconAsclepiX Therapeutics's main headquarters is located at 301 West 29th Street Suite 2004 Baltimore, Maryland 21211 US. The company has employees across 2 continents, including North AmericaAsia.

What is AsclepiX Therapeutics's official website and social media links?

Minus sign iconPlus sign iconAsclepiX Therapeutics's official website is asclepix.com and has social profiles on LinkedIn.

How much revenue does AsclepiX Therapeutics generate?

Minus sign iconPlus sign icon As of October 2024, AsclepiX Therapeutics's annual revenue reached $750K.

What is AsclepiX Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconAsclepiX Therapeutics's SIC code is 2836 - Biological Products, Except Diagnostic Substances NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AsclepiX Therapeutics have currently?

Minus sign iconPlus sign iconAs of October 2024, AsclepiX Therapeutics has approximately 10 employees across 2 continents, including North AmericaAsia. Key team members include Chief Executive Officer, President: R. D.Chief Scientific Officer, Evp-Clinical Development: A. S.Vice President Finance: J. V. T.. Explore AsclepiX Therapeutics's employee directory with LeadIQ.

What industry does AsclepiX Therapeutics belong to?

Minus sign iconPlus sign iconAsclepiX Therapeutics operates in the Biotechnology Research industry.

What technology does AsclepiX Therapeutics use?

Minus sign iconPlus sign iconAsclepiX Therapeutics's tech stack includes WordPressGoogle Font APIChoicesTippy.jsRSSPriority HintsreCAPTCHANginx.

What is AsclepiX Therapeutics's email format?

Minus sign iconPlus sign iconAsclepiX Therapeutics's email format typically follows the pattern of . Find more AsclepiX Therapeutics email formats with LeadIQ.

How much funding has AsclepiX Therapeutics raised to date?

Minus sign iconPlus sign icon As of October 2024, AsclepiX Therapeutics has raised $10M in funding. The last funding round occurred on Jul 26, 2023 for $10M.
AsclepiX Therapeutics

AsclepiX Therapeutics

Biotechnology ResearchMaryland, United States2-10 Employees

FRAUD ALERT: AsclepiX is aware of individuals representing job postings that are not legitimate positions. AsclepiX is NOT hiring at this time. 

AsclepiX Therapeutics is a clinical-stage biopharmaceutical company leveraging computational biology from Johns Hopkins to identify and develop peptides for improved treatments of retinal diseases. Our lead candidate, AXT107, inhibits pro-angiogenic vascular endothelial growth factor receptor 2 (VEGFR2) and activates the vessel stabilizing receptor tyrosine kinase (Tie2), the two validated pathways for the treatment of retinal vascular diseases.

✕

Access Insights for AsclepiX Therapeutics and Millions of Other Companies

Sign up for full access to AsclepiX Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
301 West 29th Street Suite 2004 Baltimore, Maryland 21211 US
Website
asclepix.com
SIC Code
2836 - Biological Products, Except Diagnostic Substances
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $10M

    AsclepiX Therapeutics has raised a total of $10M of funding over 3 rounds. Their latest funding round was raised on Jul 26, 2023 in the amount of $10M.

  • $10M

    AsclepiX Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    AsclepiX Therapeutics has raised a total of $10M of funding over 3 rounds. Their latest funding round was raised on Jul 26, 2023 in the amount of $10M.

  • $10M

    AsclepiX Therapeutics's revenue is in the range of $10M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for AsclepiX Therapeutics and Millions of Other Companies

Sign up for full access to AsclepiX Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.